A new study is out that compares the effectiveness of two popular weight loss drugs, Wegovy and Zepbound. The study, which ...

People who took Zepbound, Eli Lilly’s weight loss drug, shed more pounds than those on Novo Nordisk’s Wegovy in a clinical ...

Adults taking Zepbound lost 47% more weight on average than those taking Wegovy, according to clinical trial data from ...

President Joe Biden wants Medicare and Medicaid to cover weight-loss drugs, a proposal that would expand access to the costly ...

Zepbound, a drug with the main active ingredient tirzepatide, was found to be more helpful in helping people lose weight than ...

Ozempic and Wegovy might be making it harder for physicians to guide patients toward lifestyle changes − the real key to long ...

Researchers have developed and are testing a small, implanted gastric balloon that people can inflate or deflate to feel full ...

Even as weight-loss drugs such as Wegovy and Zepbound explode in popularity, many Americans struggle to afford them.

President Biden plans to roll out a new plan that would require coverage of weight loss drugs for patients of Medicare and ...

While recent advances in medicine have created prescription anti-obesity GLP-1 medications — like Ozempic, Wegovy, and ...

Dr. Matthew Knight, president of the Knight Dermatology Institute, explains how weight-loss drugs work and discusses whether ...

Eli Lilly said on Wednesday patients taking its obesity drug Zepbound lost 47% more weight than those who were given Novo ...